FDA approves use of biosimilar insulin as automatic substitute for costly brand-name
CBSN
U.S. regulators took action Wednesday that should make it easier to get a cheaper near-copy of a brand-name insulin at the drugstore.
Doctors must now prescribe what's called a biosimilar drug, or OK its use as a substitution for a more expensive brand-name insulin. The Food and Drug Administration has given its approval to Semglee, the first biosimilar cleared as a substitute for Lantus, a widely used fast-acting insulin.
Washington — Amid Trump administration demands for Tehran to keep the free flow of commerce in the Strait of Hormuz, U.S. officials have told CBS News that there are at least a dozen underwater mines through the vital passageway, according to current American intelligence assessments. Arden Farhi, Kathryn Watson, Caroline Linton, Aimee Picchi and Layla Ferris contributed to this report.

Washington — President Trump said early Monday that he is postponing airstrikes on Iran's power plants after "very good and productive conversations" over the last two days about reopening the Strait of Hormuz. However, Iran's foreign ministry denied any such talks. Claire Day contributed to this report. In:











